SCHEDULE 13D/A: Saba Capital Reduces Significant Stake in BlackRock MuniYield Pennsylvania Quality Fund
Beneficial Ownership Update
Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 13 to their Schedule 13D, disclosing a reduced beneficial ownership of 16.06% in BlackRock MuniYield Pennsylvania Quality Fund following recent open market sales.
Summary
- Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (the "Reporting Persons") jointly filed Amendment No. 13 to their Schedule 13D.
- The filing updates their beneficial ownership in BlackRock MuniYield Pennsylvania Quality Fund (NYSE: MQA).
- As of February 11, 2025, the Reporting Persons beneficially own 2,079,553 Common Shares.
- This represents 16.06% of the outstanding common stock, calculated based on 12,949,630 shares outstanding as of July 31, 2024, as disclosed in the company's N-CSR filed October 3, 2024.
- The total amount paid to acquire the Common Shares reported herein was approximately $23,452,085.
- Since the filing of the previous Schedule 13D/A on January 21, 2025, Saba Capital has engaged in multiple open market sales of Common Shares.
- A total of 135,420 shares were sold between January 22, 2025, and February 11, 2025, with prices ranging from $11.68 to $11.99 per share.
- Funds for the purchase of Common Shares were derived from subscription proceeds from investors, capital appreciation, and margin account borrowings.
Sentiment
Score: 4
Explanation: The document is a factual disclosure of a significant institutional investor reducing its stake through open market sales. While not explicitly negative, a reduction in ownership by a large investor can be perceived as a negative signal for the company's stock, potentially indicating profit-taking or a shift in investment thesis.
Future Outlook
NA
Industry Context
This filing is an update on the beneficial ownership of BlackRock MuniYield Pennsylvania Quality Fund by Saba Capital Management, L.P., a prominent activist investor known for its focus on closed-end funds. The reported sales activity indicates a reduction in Saba Capital's stake, which could be part of a broader portfolio rebalancing or a strategic shift regarding this specific fund.
Stakeholder Impact
- Shareholders: The reduction in a significant institutional investor's stake might be viewed negatively by the market, potentially impacting investor confidence and the share price of BlackRock MuniYield Pennsylvania Quality Fund.
Key Dates
| Date | Description |
|---|---|
| 2015-11-16 | Date of power of attorney for Michael D'Angelo, incorporated by reference. |
| 2015-12-28 | Date of initial Schedule 13G filing by the Reporting Persons. |
| 2024-07-31 | Date as of which 12,949,630 common shares were outstanding, used for percentage calculation. |
| 2024-10-03 | Date of company's N-CSR filing disclosing outstanding shares. |
| 2025-01-21 | Date of the previous Schedule 13D/A filing. |
| 2025-01-22 | First reported date of Common Share sales by Saba Capital (1,658 shares at $11.99). |
| 2025-01-23 | Date of Common Share sales by Saba Capital (6,610 shares at $11.95). |
| 2025-01-24 | Date of Common Share sales by Saba Capital (4,500 shares at $11.85). |
| 2025-01-27 | Date of Common Share sales by Saba Capital (3,268 shares at $11.84). |
| 2025-01-28 | Date of Common Share sales by Saba Capital (9,850 shares at $11.87). |
| 2025-01-29 | Date of Common Share sales by Saba Capital (3,713 shares at $11.83). |
| 2025-01-30 | Date of Common Share sales by Saba Capital (5,210 shares at $11.84). |
| 2025-01-31 | Date of Common Share sales by Saba Capital (3,378 shares at $11.87). |
| 2025-02-03 | Date of Common Share sales by Saba Capital (8,648 shares at $11.87). |
| 2025-02-04 | Date of Common Share sales by Saba Capital (5,758 shares at $11.87). |
| 2025-02-05 | Date of Common Share sales by Saba Capital (24,139 shares at $11.86). |
| 2025-02-06 | Date of Common Share sales by Saba Capital (17,158 shares at $11.87). |
| 2025-02-07 | Date of Common Share sales by Saba Capital (12,696 shares at $11.74). |
| 2025-02-10 | Date of Common Share sales by Saba Capital (12,801 shares at $11.74). |
| 2025-02-11 | Last reported date of Common Share sales by Saba Capital (19,953 shares at $11.68) and date of event requiring this filing. |
| 2025-02-12 | Signature date of the Schedule 13D/A filing. |
Recommendation
holdKeywords
Saba Capital Management, BlackRock MuniYield Pennsylvania Quality Fund, Schedule 13D, beneficial ownership, investment fund, closed-end fund, share sales, SEC filing, institutional investor, Boaz R. Weinstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.